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ttp://dx.doi.org/10.1016/j.ajpath.2015.01.015Glomerulonephritis is a common cause of end-stage renal disease. Inﬁltrating leukocytes interacting with
renal cells play a critical role during the initiation and progression of glomerulonephritis, but the exact
mechanisms are not clearly deﬁned. By using the murine model of nephrotoxic nephritis, we investigated
the role of S100A8/A9 [myeloid-related protein (MRP) 8/14, calprotectin] in promoting glomerulone-
phritis. In nephrotoxic nephritis, wild-type (WT) mice with glomerulonephritis have elevated serum levels
of S100A8/A9, whereas mice deﬁcient in MRP14 (S100a9/), and hence S100A8/A9, are signiﬁcantly
protected from disease. By using bone marrow transplants, we showed that MRP14 deﬁciency is required
in both the hemopoietic and intrinsic cells for the protective effect. In vitro, both the WT bone marrowe
derived macrophages and renal mesangial cells stimulated with S100A8/A9 secrete IL-6, CXCL1, and
tumor necrosis factor a; however, Mrp14/ cells exhibit signiﬁcantly blunted proinﬂammatory re-
sponses. The interaction of WT bone marrowederived macrophages with renal microvascular endothelial
cells results in increased levels of monocyte chemotactic protein 1, IL-8, and IL-6 cytokines, which
is attenuated in Mrp14/ bone marrowederived macrophages. Data shows that S100A8/A9 plays a
critical role during glomerulonephritis, exerting and amplifying autocrine and paracrine proinﬂammatory
effects on bone marrowederived macrophages, renal endothelial cells, and mesangial cells. Therefore,
complete S100A8/A9 blockade may be a new therapeutic target in glomerulonephritis. (Am J Pathol
2015, 185: 1264e1274; http://dx.doi.org/10.1016/j.ajpath.2015.01.015)Supported by Medical Research Council grant G0802260/2 for a Clinical
Research Training Fellowship (R.J.P.) and Kidney Research UK.
Disclosures: None declared.S100A8 and S100A9, members of the S100 family of
proteins, are released from phagocytes at sites of inﬂam-
mation, and are termed damage-associated molecular
patterns or alarmins. The two molecules can be expressed
as homodimers or form a heterodimer of S100A8/A9
(termed calprotectin), which is expressed in neutrophils,
monocytes, and early differentiated macrophages,1 but not
resident tissue macrophages.2 S100A8/A9 is an endoge-
nous ligand of Toll-like receptor-4 (TLR4),3 as well as the
receptor for advanced glycation end products.4,5 S100A8
is the active component of the heterodimer, whereas
S100A9 regulates S100A8 activity.3 Both S100A8 and
S100A9 are up-regulated by proinﬂammatory cytokines
tumor necrosis factor a (TNF-a) and IL-1b,6 with lipopoly-
saccharide (LPS) and interferon-g7 inducing translocationstigative Pathology.
.of S100A8 and S100A9 from the cytoplasm to the cell
surface.
We previously demonstrated that patients with active
generalized anti-neutrophil cytoplasmic antibodyeassociated
vasculitis had elevated serum S100A8/A9 levels and greater
neutrophil and monocyte S100A8/A9 cell surface expression,
compared to patients in remission and healthy controls.8 In
addition, patients who had persistently elevated S100A8/A9
levels, despite immunosuppressive treatment, were at higher
risk of subsequent disease relapse.8 Finally, patients with
focal segmental necrotizing or crescentic anti-neutrophil
S100A8/A9 in Glomerulonephritiscytoplasmic antibodyeassociated glomerulonephritis demon-
strated glomerular inﬁltration with predominant S100A8/
A9-expressing macrophages, whereas the less inﬂammatory
(sclerotic) class of glomerulonephritis contained S100A8/A9-
negative macrophages.8 These data linked S100A8/A9 with
active systemic vasculitis and glomerulonephritis.
Aswell as being a potential disease biomarker, S100A8/A9
exerts several paracrine and autocrine effects, which suggest it
may have a more direct pathogenic role in vasculitis and
glomerulonephritis. S100A8/A9 stimulation of monocytes/
macrophages, acting through TLR4, activates NF-kB and
other transcription factors, leading to increased production of
metalloproteinases9,10 and proinﬂammatory cytokines,11 as
well as stimulating autoreactive IL-17eproducing T cells12
implicated in vasculitic inﬂammation and glomerulone-
phritis. In addition, the ability of S100A8/A9 to bind the
endothelium via heparin sulfate moieties and carboxylated
glycans13,14 results in release of leukocyte chemoattractants,
such as CXCL1, and induces endothelial cell (EC) necrosis
and apoptosis, leading to disruption of the EC mono-
layer,15,16 a characteristic feature of vasculitis and crescentic
glomerulonephritis.
Experimental glomerulonephritis is characterized by a
dynamic interaction between intrinsic renal cells and inﬁl-
trating leukocytes. Neutrophils and proinﬂammatory mac-
rophages play a central role in the initiation and progression
of many forms of glomerulonephritis,17,18 whereas other
macrophage phenotypes are associated with reparative ac-
tions.19,20 Intrinsic renal cell TLR4 stimulation is key in
promoting glomerular crescent formation and thrombosis,21
whereas TLR4 deﬁciency promotes protection from exper-
imental nephrotoxic nephritis (NTN). Similarly, in the anti-
myeloperoxidase glomerulonephritis model, administration
of highly puriﬁed LPS with myeloperoxidase results in
augmented glomerular neutrophil inﬂux, an effect mediated
through TLR4 expressed on glomerular ECs, and other
intrinsic renal cells, including podocytes and mesangial
cells.22 Mice deﬁcient in Mrp14/ (S100a9/) also lack
MRP8 (S100a8) protein and cannot form the calprotectin
(MRP8/14) heterodimer.23
Therefore, we hypothesized that S100A8/A9 (calpro-
tectin) may play a role in the pathogenesis of glomerulo-
nephritis by exerting a proinﬂammatory effect on inﬁltrating
macrophages and intrinsic renal cells. We tested this hy-
pothesis by performing NTN in wild-type (WT) and
Mrp14/ (calprotectin-lacking) mice.
Materials and Methods
Animals
Mrp14/ mice were kindly provided by Prof. Fredrik Ivars
(University of Lund, Lund, Sweden). Mrp14/ mice were
generated as previously described.24 Homozygous mice, aged
8 to 12 weeks, were used for experiments and were bred at the
Central Biological Services Unit, Hammersmith HospitalThe American Journal of Pathology - ajp.amjpathol.orgCampus, Imperial College London (London, UK). Control
mice were age and sex matched. C57BL/6 control mice used
at the Hammersmith Hospital (London, UK) were obtained
from Charles River Laboratories. Control C57BL/6 mice at
UCL Centre for Nephrology (London, UK) were bred within
the animal house. The mice were bred in a pathogen-free
environment with access to food and water. Experiments
were performed in accordance with Home Ofﬁce guidelines.
Serum Levels of Murine S100A8/A9
S100A8/A9 concentration in mouse serum was determined
by enzyme-linked immunosorbent assay (ELISA), using an
ELISA protocol, as previously described.3
Immunohistochemistry to Detect Expression of
S100A8/A9-Positive Cells, Macrophages, CD4þ T Cells,
and Granulocytes
Immunoperoxidase staining was performed using the Polink-
2 HRP Plus kit (Newmarket Scientiﬁc, Newmarket, UK).
Sections (5 mm thick) of periodate-lysine-paraformaldehyde
ﬁxed tissue were used. Endogenous peroxidase activity was
blocked with 3% hydrogen peroxide for 10 minutes. Sub-
sequently, after rinsing the sections in distilled water, sec-
tions were blocked with skimmed milk (Marvel; Premier
International Foods, Spalding, UK) for 30 minutes. The
sections were then incubated with the primary antibody
diluted in phosphate-buffered saline (PBS): rat anti-mouse
CD68 (Serotec, Oxford, UK) and rat anti-mouse CD4 (BD
Pharmingen, San Diego, CA), both at a dilution of 1:100, rat
anti-mouse S100A8/A9 antibody (a kind gift from Dr.
Nancy Hogg, Cancer Research UK London Research
Institute, London, UK; dilution 1:120), and the granulocyte
marker GR01 (Serotec; dilution 1:50). Negative controls
were also included in which the primary antibody was
replaced with PBS. The sections were incubated with the
primary antibody for 1 hour in a humidiﬁed chamber at
room temperature. After incubation, sections were washed
in PBS and two drops of antibody enhancer were then
added to each section for 10 minutes. Slides were washed
three times, and two drops of the polymerehorseradish
peroxidase were incubated with the sections for a further
10 minutes. Slides were washed three times in PBS, and
the detection antibody was made up by adding two drops
of the 3,30-diaminobenzidine chromagen solution to 1 mL
of diaminobenzidene substrate. Once brown color devel-
opment was obtained, slides were rinsed in distilled water
and counterstained in ﬁltered Harris hematoxylin (Cell
Path PLC, Powys, UK) for 30 seconds. Followed by a
rinsing step in distilled water, the slides were brieﬂy
placed in acid alcohol, followed by a washing step for 5
minutes until the sections turned blue. Sections were
dehydrated by serial immersions for 3 minutes each in
100% ethanol twice and xylene twice, before mounting
with DePeX Gurr mounting medium (BDH Prolabo1265
Pepper et alChemicalseVWR International Ltd, Lutterworth, UK) and
coverslip placement.
Immunoﬂuorescence Staining
Direct immunoﬂuorescence was performed on PLP-ﬁxed
frozen kidney sections to detect mouse and sheep IgG. Goat
serum (20%; Sigma, St. Louis, MO) was applied to block non-
speciﬁc binding, followed by either goat anti-mouse IgG
ﬂuorescein isothiocyanate (Sigma), 1:200, or monoclonal anti-
goat/sheep IgG ﬂuorescein isothiocyanate (Sigma), 1:200, for
1 hour in a humidiﬁed chamber. Antibodies were diluted in
PBS. After washing the sections, theyweremounted in Citiﬂor
AF1 solution (VWR, Radnor, PA).
Systemic Immune Response to Sheep IgG Analysis
Serum mouse anti-sheep IgG levels were measured by
ELISA. ELISA plates (Nunc Maxisorb; Life Technologies,
Paisley, UK) were coated overnight at 4C with 100 mg/mL
of sheep IgG (Sigma) diluted in 100 mmol/L boric acid. After
a blocking step, serum was diluted 1:1000 in 1% bovine
serum albumin. Alkaline phosphataseeconjugated goat anti-
mouse IgG (Southern Biotechnology, Birmingham, AL) at
1:1000 in 1%bovine serum albuminwas used as the secondary
antibody. All incubations were for 1 hour at 37C. Plates were
developed using p-nitrophenyl phosphate (Sigma-Aldrich) and
measured on an ELISA plate reader at 405 nm.
Induction of NTN
To induce accelerated NTN, mice were initially preimmunized
with 0.2 mg of sheep IgG (Sigma-Aldrich) made up in 0.9%
sterile saline, mixed in a ratio of 1:1 with complete Freund
adjuvant (Sigma-Aldrich). Five days after the immunization,
the mice were injected with 200 mL sheep nephrotoxic globulin
diluted 1:1 in 0.9% NaCl, via the tail vein. Nephrotoxic glob-
ulin serum was generated as previously described.25 Mice were
placed in metabolic cages for 24 hours 1 day before they were
humanely sacriﬁced 7 to 9 days after nephrotoxic globulin in-
jection. The kidneys were harvested, and urine and blood were
collected. For the nonaccelerated model of NTN,mice were not
preimmunizedwith sheep IgG. Instead, micewere injectedwith
200 mL of nephrotoxic serum diluted 1:1 with sterile saline
(0.9%) into the tail vein and sacriﬁced 2 hours later.
Bone Marrow Transplantation
To obtain donor bone marrow from WT and Mrp14/
mice, the femurs and tibias were dissected, followed by
ﬂushing through the bone with sterile PBS, and bone
marrow cells were collected. The cells were resuspended in
RPMI 1640 media, and 10 million cells were injected i.v.
into the tail vein per mouse.
The female recipients of the bone marrow were irradiated
in an IBL 637 irradiator (CIS Bio International, Saclay,1266France), with a dose of 8 Gy. Within an hour of receiving this
dose of radiation, the mice were transplanted with donor bone
marrow cells. After transplantation, the mice were kept for 8
weeks before undergoing NTN. Bone marrow reconstitution
was conﬁrmed by PCR analysis of circulating leukocytes.
T-Cell Proliferation Assay
After NTN and sacriﬁce of the animals, the spleens were
harvested and single-cell suspensions were isolated, followed
by red cell lysis. Splenocytes (1  105) were cultured in
triplicate in HL-1 serum-free media (Lonza Group Ltd, Basel,
Switzerland) alone, with CD28/CD3 beads (InvitrogeneLife
Technologies, Carlsbad, CA) or with aggregated sheep IgG
(10 and 50 mg/mL) for 72 hours. After the stimulation, 1 mCi
of 3H thymidine was added to each well, followed by incu-
bation for a further 24 hours at 37C. Thymidine uptake was
then counted after 24 hours using a 1450 MicroBeta TriLux
liquid scintillation and luminescence counter (counts per
minute; PerkinElmer, Waltham, MA).
Histological Analysis
Sections were blinded so the animal identity was unknown.
To calculate a score for glomerular thrombosis, periodic
acideSchiff kidney sections were used to grade the amount
of periodic acideSchiffepositive material occupying the
glomeruli above normal staining. The glomeruli were scored
according to the number of quadrants affected, as follows:
0 indicates no thrombosis in any quadrant; 1 indicates one
quadrant with thrombosis observed; 2 indicates two quad-
rants of the glomerulus affected; 3 indicates three of the
quadrants affected; 4 indicates that all 4 quadrants were
affected (maximum score, 4). Some sections were also
stained for ﬁbrin (Abcam, Cambridge, UK) to validate the
thrombosis scoring. Glomerular macrophages and T cells
identiﬁed on immunoperoxidase staining were also counted.
Twenty-ﬁve glomeruli were counted, and the mean score
was then calculated for each mouse. Immunoﬂuorescence
sections were scored using Image Pro Plus software (Media
Cybernetics, Rockville, MD). To quantitate using Image Pro
Plus, images of glomeruli were captured using a QImaging
Retiga 2000R Fast 1396 camera (QImaging, Surrey, BC,
Canada). For each section, 10 glomeruli were examined and
the mean ﬂuorescence intensity recorded. Where Image Pro
Plus software was used, results are expressed in arbitrary
ﬂuorescence units.
Isolation of BMDMs
After sacriﬁce of the animals, the femurs and tibias were
isolated in a sterile manner. The collected bone marrow was
washed with Hanks media and spun at 524 g for 5 minutes.
The cells were resuspended in sterile culture medium of
Dulbecco’s modiﬁed Eagle’s medium (DMEM; Invitrogen)
supplemented with 20% fetal calf serum (FCS; Biosera,ajp.amjpathol.org - The American Journal of Pathology
S100A8/A9 in GlomerulonephritisBoussens, France), 100 U/mL penicillin (Gibco Life Tech-
nologies, Grand Island, NY), 100 mg/mL streptomycin,
and 25% L929 cell (European Collection of Cell Cultures,
Salisbury, UK) conditioned media containing macrophage-
speciﬁc colony-stimulating factor. The cells were cultured
at 37C, in 5% CO2. After 3 days, the media were replaced
with the removal of the nonadherent cells. Fresh media were
added. The macrophages were harvested at day 7, and used
for stimulation experiments 24 hours later.
Isolation of Mesangial Cells
Kidneys were removed from WT and Mrp14/ mice and
placed in RPMI media (Invitrogen) with penicillin/strepto-
mycin. The kidneys were blended, followed by sequential
sieving using size 70-mm, then size 40-mm, sieves. Glomeruli
were collected on the smaller sieve and spun down at 233  g
for 5 minutes, followed by a digestion step of collagenase
(Sigma-Aldrich) for 30minutes at 37C. Thiswas followed by a
centrifuge step and resuspension in RPMImedia, supplemented
with glutamine, 20% FCS, 100 U/mL penicillin, 100 mg/mL
streptomycin, 1% insulin/selenium/transferrin growth supple-
ment (Sigma-Aldrich), and 20 mmol/L HEPES (Invitrogen).
The cells were cultured in tissue culture ﬂasks and incubated at
37C with 5% CO2. Media were replaced every 2 to 3 days.
Mesangial cells were used between passage 6 and 12.
Isolation of WT Kidney ECs
Kidneys fromWTmice were harvested and placed in DMEM
on ice. The kidneys were blended using a syringe plunger,
passed through a 70-mm sieve, and digested using 3 mg/mL
collagenase (Sigma-Aldrich) in an agitated water bath at 37C
for 30 minutes. The digested cells were collected and washed
twice in DMEM/0.5% FCS and resuspended in media before
incubation with rat anti-mouse CD31 and rat anti-mouse
CD105 (both from BD Pharmingen) at 4C for 30 minutes.
After two washes, cells were resuspended in 0.5% FCS/
DMEM and goat anti-rat microbeads (Miltenyi Biotec,
Cologne,Germany), and incubated for 15minutes at 4C.After
a washing step, the cells were passed through the magnet and
retained cells were collected and placed into a 25-cm ﬂask,
which had been precoated with 2% gelatin (Sigma-Aldrich).
The cells were cultured in GlutaMAX DMEM (Gibco Life
Technologies), 20% FCS, endothelial growth supplement
(Sigma-Aldrich), 100 U/mL penicillin, and 100 mg/mL strep-
tomycin. Media were changed every 3 days. When conﬂuence
was achieved, cells were split into different culture ﬂasks. The
cells were used for experiments at passage 8 to 12. The
phenotype of the isolated cells was conﬁrmed by positive
staining with anti-CD31 immunoﬂuorescence.
Co-Culture of ECs and Macrophages
Cultured ECs were plated into a 6-well plate (Corning; Nunc,
Rochester, NY). Cells (320,000 cells per well) were platedThe American Journal of Pathology - ajp.amjpathol.orgout and left to grow in DMEM/10% FCS for 48 hours. The
media were then aspirated. Bone marrowederived macro-
phages (BMDMs) from WT and from Mrp14/ mice were
grown and were isolated on day 7. BMDMs (1  106) were
added to the ECs in DMEM. Each group of cells was co-
cultured in triplicate. The cells were incubated at 37C with
5% CO2 for 24 hours. The supernatants were then collected
and kept at 20C before cytokine analysis by ELISA.
Co-Culture and Stimulation of Podocytes
Immortalized mouse podocytes (a gift from Dr. Peter Mundel,
Mount Sinai School of Medicine, New York, NY) were
cultured on tissue culture plastic coated with 1% Matrigel
substrate. For ongoing proliferation, cells were cultured at
33C in a 5% CO2 incubator in RPMI (Invitrogen) supple-
mented with 10% FCS (Invitrogen), antibiotics, and 10 U/mL
interferon-g. To induce differentiation, cells were ther-
moshifted to 37C and cultured in RPMI in the absence of
interferon-g. Cells were allowed to differentiate under these
conditions for 14 days. Cells (50,000 cells per well) were
seeded and allowed to attach overnight before incubation for
24 hours with S100A8/A9. Supernatants were collected and
used for cytokine analysis.
Mesangial Cell Proliferation Assay
Mesangial cells were used between passage 6 and 12.
Proliferation was measured by bromodeoxyuridine cell
proliferation assay (Millipore, Billerica, MA) and MTT
assay (Life Technologies). Cells were plated at 1 104 cells
per well of a 96-well ﬂat-bottom plate (Corning: Appleton
Woods, Birmingham, UK) in triplicate. After 24 hours of
incubation, the cells were washed with warm Dulbecco’s
PBS (Life Technologies) and incubated in RPMI 1640
medium with L-glutamine, 1% penicillin, and 0.2% fetal
bovine serum, with or without S100A8/9. Bromodeox-
yuridine reagent was added after 4 hours of serum starva-
tion and cells were incubated for a further 24 hours, when
the assay was performed according to the manufacturer’s
instructions. TheMTT assay was performed after 72 hours’
incubation, according to the manufacturer’s instructions.
Supernatant ELISAs
Several cytokine ELISAs were used to analyze cytokine
production. Supernatants were collected and kept at 20C
until use. The dilutions for each individual cytokine were
optimized and varied accordingly. Monocyte chemotactic
protein (MCP)-1 and IL-6 were measured using mouse che-
mokine ligand 2 (MCP-1) ELISA Ready-SET-Go and IL-6
ELISA Ready-SET-Go kit (eBiosciences, Insight Biotech-
nology Ltd, Wembley, UK), according to the manufacturer’s
instructions. TNF-a and CXCL1 were analyzed using Duoset
ELISA Development System (R&D Systems, Abingdon,
UK), according to the manufacturer’s instructions.1267
Figure 1 A: Glomerular S100A8/A9 and macrophage CD68 expression in
the accelerated nephrotoxic nephritis model in wild-type (WT) mice (nZ 9).
Number of cells per glomerular cross section was counted (for 25 glomeruli),
mean of 3.53 (SD, 1.0) CD68-positive macrophages per glomerular section in
WT animals, whereas there was a mean of 1.22 (SD, 0.6) S100A8/A9 cells per
glomerular section. B: Graph shows the serum levels of S100A8/A9 in WT
mice after nephrotoxic nephritis and in WT controls in which disease has not
been induced. The serum level of S100A8/A9 is signiﬁcantly higher in mice
with nephrotoxic nephritis (P< 0.0005). GCS, glomerular cross section; NTN,
nephrotoxic nephritis.
Pepper et alStatistical Analysis
The animal study results are expressed as median (range).
All statistics were performed using GraphPad Prism soft-
ware version 4.0 (GraphPad Software, San Diego, CA).
Nonparametric tests of signiﬁcance were applied. For
comparing two groups, U-test was used, as well as the
paired t-test, whereas one-way analysis of variance was
performed using nonparametric Kruskal-Wallis test and
Dunn’s multiple comparison post test for groups of three or
more. Two-way analysis of variance was used to analyze
differences between groups from more than one experiment.
Correlations were assessed using the nonparametric
Spearman rank correlation analysis. A signiﬁcant value was
deﬁned as P < 0.05 with 95% conﬁdence.
Results
S100A8/A9 Macrophage Expression and Serum Levels
in NTN
We ﬁrst investigated the inﬁltration of proinﬂammatory
S100A8/A9-expressing macrophages and measured the
serum levels of S100A8/A9 in WT mice after the induction
of NTN (nZ 9). The autologous model of NTN was used in
which mice were preimmunized with sheep IgG, followed by
injection of sheep nephrotoxic serum days later. Eight days
after disease induction, mice were sacriﬁced. The mean total
number of CD68-positive macrophages per glomerular cross
section was counted for each animal and compared with the
number of glomerular S100A8/A9-positive cells from the
same animals. There was a mean of 3.53 (SD, 1.0) CD68-
positive macrophages per glomerular section in WT ani-
mals with NTN, whereas there was a mean of 1.22 (SD, 0.6)
S100A8/A9 cells per glomerular section (Figure 1). Histo-
logically, the S100A8/9-positive cells were mononuclear and
did not have the morphological features of neutrophils,1268demonstrating that S100A8/A9-positive monocytes/macro-
phages are recruited into the glomerulus during glomerulo-
nephritis. In addition, serum levels of S100A8/A9 after NTN
were signiﬁcantly elevated, with a median S100A8/A9 level
of 2949 ng/mL (range, 309 to 31,428 ng/mL), compared to a
level of 3 ng/mL in normal control mice without NTN (range,
0 to 210 ng/mL) (P < 0.0005; Mann-Whitney U -test).
Moreover, there were signiﬁcant positive correlations be-
tween S100A8/A9 serum levels and disease outcome mea-
sures, such as serum urea (rZ 0.74, P < 0.05, Spearman’s
rank) and glomerular thrombosis (r Z 0.9, P < 0.005,
Spearman’s rank). Overall, this demonstrates there is a subset
of S100A8/A9-positive macrophages within inﬂamed
glomeruli, and mice with the most severe disease have the
highest serum S100A8/A9 levels, replicating the link be-
tween serum S100A8/A9 levels and disease severity found in
anti-neutrophil cytoplasmic antibodyeassociated vasculitis
patients.
Mrp14/ Mice Demonstrate Signiﬁcantly Less Disease
than WT Mice during NTN
To elucidate whether mice deﬁcient in MRP14 (and therefore
deﬁcient in the S100A8/A9 heterodimer) are protected from
signiﬁcant renal inﬂammation, we induced NTN (autologous
model) in WT and Mrp14/ mice. Three independent ex-
periments were performed and parameters (renal function,
glomerular thrombosis, macrophage inﬁltration, and pro-
teinuria) combined after analysis by two-way analysis of
variance. These experiments demonstrated signiﬁcant dif-
ferences between the WT (nZ 26) and Mrp14/ (nZ 24)
mice after NTN induction, with differences in glomerular
thrombosis score [WT median, 0.44 (range, 0 to 4);Mrp14/
median, 0 (range, 0 to 3.28)] (P < 0.005), proteinuria [WT
median, 1.532 mg/day (range, 0 to 29.49 mg per day);
MRP14/ median, 0.48 mg/day (range, 0 to 9.48 mg per
day)] (P < 0.05), and renal function assessed by serum urea
levels [WT median serum urea, 11.55 mmol/L (range, 6.6 to
139 mmol/L); Mrp14/ median serum urea, 7.55 mmol/L
(range, 3.2 to 69mmol/L)] (P< 0.001) (Figure 2). In addition,
ﬁbrin deposition reﬂected the glomerular thrombosis scores
with signiﬁcantly more ﬁbrin deposition (quadrants affected
per glomeruli) in the WT mice compared to Mrp14/ mice
[WT median, 1.6 (range, 0 to 3.2); Mrp14/, 0.32 (range,
0 to 0.68)] (P < 0.05).
Assessing immune responsiveness using immunohisto-
chemistry, WT mice demonstrated a signiﬁcantly greater
degree of macrophage inﬁltration compared with Mrp14/
animals in all of the experiments, but there were differences in
absolute numbers between experiments.Overall, the difference
was highly signiﬁcant, WT median number of macrophages/
glomerular cross section was 1.72 (range, 0 to 4.96), compared
with Mrp14/ median, 0.6 (range, 0 to 2.64) (P < 0.001)
(Figure 2). By contrast, there was no signiﬁcant difference in
CD4þ T-cell inﬁltration between WT and Mrp14/ mice
[median number of glomerular CD4þ T cells/glomerular crossajp.amjpathol.org - The American Journal of Pathology
Figure 2 A: Thrombosis score of the wild-type
(WT) and Mrp14/ mice in the three experiments,
with signiﬁcantly less thrombosis in the Mrp14/
mice. B: Combined proteinuria results from the
three experiments. C: Serum urea levels in the two
animal groups: WT mice have signiﬁcantly higher
urea than Mrp14/ mice. D: The number of CD68-
positive cells per glomerular cross section in WT
and Mrp14/ animals. Medians are shown. E:
Photomicrograph shows CD68 macrophage immu-
nohistochemistry in Mrp14/ mice, with few
macrophages inﬁltrating the glomerulus. F:
Photomicrograph shows the CD68 macrophage
immunohistochemistry in WT mouse with severe
disease. G: Inﬁltration of S100A8/A9 cells into the
glomerulus of WT mice. H: Photomicrographs of
glomeruli (periodic acideSchiff stain) to demon-
strate mouse glomerulus without nephrotoxic
serum administration. I: Mrp14/ mouse after
nephrotoxic nephritis demonstrating a normal
glomerulus. J: WT mouse demonstrating a throm-
bosed glomerulus and severe disease. *P < 0.05,
***P < 0.001. Original magniﬁcation, 400 (G).
GCS, glomerular cross section.
S100A8/A9 in Glomerulonephritissection WT, 0.12 (range, 0 to 0.21) versus Mrp14/, 0.12
(0 to 0.33)] (not signiﬁcant). T-cell proliferation was
compared between WT and Mrp14/ mice after NTN.
Background splenocyte proliferation (media alone) was
subtracted from proliferation in response to anti-CD3/CD28
or sheep IgG. There was no signiﬁcant difference between
the two animal groups in response to anti-CD3/CD28, low-
dose sheep IgG (10 mg/mL), and high-dose sheep IgG
(50 mg/mL) (data not shown).
Deposited sheep and mouse IgGs were assessed by direct
immunoﬂuorescence in all of the experiments, and quanti-
ﬁed using image analysis software. Levels were similar in
WT and Mrp14/ mice [median mouse IgG deposition:
WT, 96.18 arbitrary units (AUs) (range, 65.35 to 140.2 AU)
versus Mrp14/, 123.1 AU (range, 66.26 to 165 AU) (not
signiﬁcant); glomerular sheep IgG deposition: WT, 25.96
AU (range, 21.69 to 46.53 AU) versus Mrp14/, 38.76 AU
(range, 22.14 to 66.44 AU) (not signiﬁcant)]. Finally, total
mouse anti-sheep IgG was measured by ELISA and
demonstrated no difference in the IgG response between the
two animal groups in the independent NTN experiments (data
not shown). This particular nephrotoxic serum resulted in a
thrombotic glomerulonephritis rather than a predominantlyThe American Journal of Pathology - ajp.amjpathol.orgcrescentic phenotype, so glomerular lesions were not scored
for crescents. Overall, mice deﬁcient in Mrp14/ demon-
strated signiﬁcantly less renal injury than WT mice, with
preserved renal function, less proteinuria, reduced macrophage
inﬁltration, and attenuated glomerular thrombosis, but with no
difference demonstrated in humoral or T-cell responses.
Disease Protection in Mrp14/ Mice Is Overcome by
TLR4 Stimulation Using LPS
Because S100A8/A9 mediates some of its proinﬂammatory
effects through TLR4, we examined if the administration of
another TLR4 agonist (LPS) to Mrp14/-deﬁcient mice
would overcome the deﬁciency of S100A8/A9 and result in
similar renal disease to WT animals. The autologous NTN
model was repeated in WT and Mrp14/ mice, but 3 days
after the administration of nephrotoxic serum, each mouse
in both groups received 1 mg LPS i.p. Mrp14/ mice
administered LPS developed similar renal damage as WT
mice administered LPS, with equivalent glomerular throm-
bosis scores, proteinuria, renal dysfunction, and glomerular
CD68 macrophage inﬁltration (data not shown). These data
demonstrate that MRP14 deﬁciency and, hence, deﬁcient1269
Figure 3 The results of nephrotoxic nephritis in bone marrow chimeras show no difference in glomerular thrombosis (A), proteinuria (mg/24 hours; B),
and serum urea levels (mmol/L; C) between the three animal groups [wild type (WT) to WT, Mrp14/ to WT, and WT to Mrp14/].
Pepper et alendogenous TLR stimulation are protective but can be
overcome by excess exogenous TLR4 stimulation.
Disease Protection in Mrp14/ Mice Is Not Due to
Defective Neutrophil Recruitment
To assess the early glomerular neutrophil inﬂux in response
to nephrotoxic serum and to investigate whether Mrp14/
failed to recruit glomerular neutrophils, which mediate this
early glomerular damage, we performed the heterologous
nonaccelerated NTN model in Mrp14/ and WT mice. The
ﬁrst heterologous phase occurs after injection of the neph-
rotoxic serum when the sheep antibody is planted on the
glomerular basement membrane, resulting in neutrophil
inﬁltration and mild proteinuria, and occurs within the ﬁrst
few hours.26
We examined neutrophil inﬁltration at 2 hours in WT and
Mrp14/ mice (n Z 9 for each), assessed by immuno-
histochemistry using the granulocyte marker GR-1. No
difference in the early neutrophil inﬂux between WT and
Mrp14/ mice was found [median neutrophil number at 2
hours in the WT mice, 0.6 (range, 0.44 to 2) and in
Mrp14/, 0.71 (range, 0.56 to 1.2); P > 0.05]. This
demonstrates that disease protection in Mrp14/ mice
during NTN was not due to diminished glomerular
neutrophil chemotaxis.
MRP14 Deﬁciency in Both Circulating and Intrinsic
Cells Is Required for Disease Protection
To understand whether MRP14-deﬁcient circulating cells or
resident renal cells are required for disease protection, we
performed bone marrow transplants in which Mrp14/
bone marrow was transplanted into irradiated WT mice, and
WT bone marrow into Mrp14/ mice (n Z 9 for each).
Controls had WT bone marrow transplanted into WT re-
cipients (n Z 8). PCR demonstrated successful reconstitu-
tion with donor bone marrow (>95%). Eight weeks after the
bone marrow transplantation, NTN was performed. There
was no difference between the three groups with regard to1270disease severity assessed by serum urea [median serum urea
in the WT to WT group, 23 mmol/L (range, 4.6 to 53.2
mmol/L); in the Mrp14/ to WT group, 37.5 mmol/L
(range, 6.1 to 210 mmol/L); and in the WT to Mrp14/
group, 38.9 mmol/L (range, 7.1 to 234 mmol/L)], glomer-
ular thrombosis [median glomerular thrombosis score in the
WT to WT group, 1.72 (range, 0 to 3.26); in the Mrp14/
to WT group, 1.58 (range, 0 to 3.52); and in the WT to
Mrp14/ group, 2.08 (range, 0.3 to 64)], or proteinuria
[median 24-hour proteinuria (mg/24 hours) in the WT to
WT group, 9.83 mg (range, 2.7 to 16.86 mg); in the
Mrp14/ to WT group, 8.95 mg (range, 0.45 to 32.8 mg);
and in the WT to Mrp14/ group, 2.73 (range, 0.58 to
31.68)] (Figure 3). These data demonstrate that deﬁciency
of MRP14 and, therefore, MRP8/14 (S100A8/9) was
necessary in both circulating hemopoietic cells and radio-
resistant intrinsic cells for disease protection, suggesting that
intrinsic cells would be capable of producing and respond-
ing to S100A8/9.
Mrp14/ BMDMs and Renal Mesangial Cells Have
Diminished Responses to the Proinﬂammatory Effects
of S100A8/A9
We investigated whether S100A8/A9 mediates similar
proinﬂammatory actions in WT and Mrp14/ BMDMs and
intrinsic renal mesangial cells, known to play a critical role
during experimental glomerular inﬂammation, by assessing
CXCL1, TNF-a, IL-6, and MCP-1 cytokine secretion.
Mesangial cells were characterized by their morphological
features and positive staining for myosin and negative
staining for pancytokeratin using immunoﬂuorescence (data
not shown). On stimulation with S100A8/A9, the Mrp14/
cells produced signiﬁcantly less cytokines thanWT cells. For
BMDMs, the median increase compared to unstimulated
cells of CXCL1 in WT cells was 3749 pg/mL (range, 3199
to 4482 pg/mL) and in Mrp14/, 659 pg/mL (range, 209
to 792 pg/mL) (P < 0.005); median increase in TNF-a in
WT BMDMs, 272 pg/mL (range, 202.6 to 309.9 pg/mL) and
in Mrp14/ BMDMs, 33.4 pg/mL (range, 29.2 toajp.amjpathol.org - The American Journal of Pathology
Figure 4 Bone marrowederived macrophage (BMDM) cytokine production in wild-type (WT) and Mrp14/ cells, after stimulation with exogenous S100A8/
A9: CXCL1 (A), tumor necrosis factor (TNF)-a (B), and IL-6 (C) secretion. There is signiﬁcantly greater cytokine production in WT BMDMs when stimulated with
S100A8/A9 (one-way analysis of variance). Mrp14/ cells stimulated with S100A8/A9 do not produce a signiﬁcant increase in cytokine production. Median
and range are shown. *P < 0.05.
S100A8/A9 in Glomerulonephritis66.7 pg/mL) (P < 0.05); and median increase in IL-6 in WT
BMDMs, 96.5 pg/mL (range, 58 to 106.4 pg/mL) and in
Mrp14/ BMDMs, 12.2 pg/mL (range, 11.5 to 16.2
pg/mL) (P < 0.05) (Figure 4). For mesangial cells, the
median increase after S100A8/9 stimulation of CXCL1 in
WT cells was 267.8 pg/mL (range, 230.5 to 288.1 pg/mL)
and in Mrp14/ cells, 81.28 pg/mL (range, 67.62 to 87.87
pg/mL); median increase in MCP-1 in WT mesangial cells
was 403.7 pg/mL (range, 311.2 to 491.5 pg/mL) and in
Mrp14/cells, 103 pg/mL (range, 99.4 to 103.9 pg/mL)
(all P < 0.005). However, Mrp14/ mesangial cells pro-
duced a greater amount of IL-6 than WT mesangial cells
after S100A8/9 stimulation [median increase in IL-6 in WT
cells, 0 pg/mL (range, 0 to 2.59 pg/mL) and in Mrp14/
cells, 6.76 pg/mL (range, 6.7 to 14.29 pg/mL)] (P < 0.05).
Figure 5 demonstrates the cytokine production by mesan-
gial cells. Finally, we tested the effect of S100A8/A9
stimulation on mesangial cell proliferation assessed using
bromodeoxyuridine incorporation (media alone mean 
SD, 0.538 AU  0.01; S100A8/9 mean, 0.545 AU  0.006;
not signiﬁcant) and MTT assays (media alone mean, 0.197
AU  0.01; S100A8/9 mean, 0.216 AU  0.007; notFigure 5 The increase in wild-type (WT) and Mrp14/ mesangial cell cytok
signiﬁcantly less CXCL1 than WT cells (A), less monocyte chemotactic protein (MCP
shown. *P < 0.05, ***P < 0.005.
The American Journal of Pathology - ajp.amjpathol.orgsigniﬁcant), and found no evidence of cell proliferation after
exposure to S100A8/9.
Therefore, BMDMs and mesangial cells deﬁcient in
Mrp14/ demonstrate decreased inﬂammatory responses to
S100A8/A9. These data suggest that there is a critical
requirement for endogenous S100A8/A9 production, to
enable cytokine production in response to S100A8/A9
stimulation.
Co-Culture of ECs with BMDM Stimulates Inﬂammatory
Cytokine Production, Which Is Diminished with
Mrp14/ BMDMs Compared to WT Cells
The interaction between the endothelium and leukocytes is
critical in the pathogenesis of vasculitis and glomerulone-
phritis. We investigated the proinﬂammatory interaction
when BMDMs are cultured with renal microvascular ECs
and compared the effect of WT and Mrp14/ BMDMs.
After isolation of renal microvascular ECs from the kid-
neys of WT mice, the phenotype of the renal ECs was
conﬁrmed by positive staining for CD31 by immunoﬂuo-
rescence (data not shown). The following cell conditionsine production when stimulated with S100A8/A9. Mrp14/ cells produce
-1; B), but a greater amount of IL-6 than WT cells (C). Median and range are
1271
Figure 6 Cytokine production in endothelial cell (EC)ebone marrowederived macrophage (BMDM) co-culture. CXCL1 (A), monocyte chemotactic protein
(MCP-1; B), and IL-6 (C) production during EC co-culture with wild-type (WT) or Mrp14/ BMDMs. In all cases, cytokine production is signiﬁcantly greater in
EC-WT BMDM co-culture compared with EC-MRP14/ co-culture. Median and range are shown. **P < 0.01.
Figure 7 Cytokine production by podocytes. Graph shows monocyte
chemotactic protein 1 (MCP-1; A) and IL-6 (B) production after stimulation
with lipopolysaccharide (LPS) or S100A8/9. S100A8/A9 alone has little
effect on podocyte MCP-1 or IL-6 production, whereas the combination of
S100A8/A9 and LPS has a similar effect to LPS alone, increasing MCP-1 and
IL-6 production compared to unstimulated cells (one-way analysis of
variance). There is a nonsigniﬁcant increase in IL-6 after combined treat-
ment, compared to LPS alone. *P < 0.05.
Pepper et alwere cultured: i) ECs alone, ii) WT BMDMs alone, iii)
Mrp14/ BMDMs alone, iv) ECs co-cultured with WT
BMDMs, and v) ECs co-cultured with Mrp14/ BMDMs.
The BMDMs cultured alone produced small quantities of
cytokines.MedianMCP-1WTBMDMwas 0.843 mg/mL and
Mrp14/ BMDM, 0.942 mg/mL (not signiﬁcant); median
CXCL1 WT BMDM was 41.88 pg/mL and Mrp14/
BMDM, 63.33 pg/mL (not signiﬁcant); and median IL-6 WT
BMDM was 56.7 pg/mL and Mrp14/ BMDM, 113.3
pg/mL (P < 0.05). ECs alone produced greater amounts of
MCP-1 compared to the two BMDM groups (medianMCP-1,
5.34 mg/mL) and greater amounts of CXCL1 (median, 237.2
pg/mL) and less IL-6 (median, 28.7 pg/mL).
However, the greatest amount of cytokine production was
after ECs co-culture with WT BMDMs, resulting in signiﬁ-
cantly greater quantities of MCP-1, CXCL1, and IL-6
compared with ECs co-cultured with Mrp14/ BMDMs,
which were similar to levels found in ECs alone. ECs co-
cultured with BMDMs resulted in MCP-1 levels with WT
BMDM median, 29.99 mg/mL, and with Mrp14/ BMDM
median, 11.85 mg/mL; CXCL1: WT BMDM median, 1000
pg/mL, and Mrp14/ BMDM median, 445 pg/mL; and
IL-6: WT BMDM median, 870.8 pg/mL, and Mrp14/
BMDM median, 181.8 pg/mL (all P < 0.01) (Figure 6).
Similar data were found after the addition of exogenous
S100A8/A9 to ECs, which resulted in augmented secretion of
CXCL1 and MCP-1 (data not shown).
The co-culture experiments illustrate the decreased in-
ﬂammatory proﬁle of BMDMs lacking S100A8/A9 when
interacting with renal microvascular ECs, conﬁrming the
critical requirement for S100A8/A9 expression on inﬁltrating
monocytes/macrophages to mediate EC inﬂammation.
Stimulation of Podocytes with S100A8/A9 Has a
Minimal Proinﬂammatory Effect
Because proteinuria is a feature of experimental glomerulo-
nephritis, we investigated the effect of S100A8/A9 on
podocytes. An immortalized podocyte cell line was stimu-
lated with the following: i) LPS (positive control), ii)1272S100A8/A9, and iii) combined LPS and S100A8/A9. There
was no TNF-a detected in any of the stimulation conditions.
For MCP-1 secretion, unstimulated cells produced a median
of 2002 pg/mL (range, 1988 to 2101 pg/mL), after LPS, 7798
pg/mL (range, 7558 to 7915 pg/mL) (P < 0.05), and after
S100A8/A9, 2633 pg/mL (range, 2423 to 2818 pg/mL) (data
not signiﬁcant). There was no synergistic effect of LPS and
S100A8/A9, which produced a median of 7150 pg/mL
(range, 6710 to 7172 pg/mL). Similar patterns were obtained
for IL-6 secretion. Unstimulated podocytes produced no
detectable IL-6. LPS stimulation resulted in a median of
44.34 pg/mL (range, 38.72 to 45.34 pg/mL), with S100A8/
A9 stimulation resulting in almost no detectable IL-6 [me-
dian, 0 (range, 0 to 21.1)]. There was a slight synergistic
effect of LPS and S100A8/A9, with a median of 54.61
(range, 47.35 to 54.81). The only statistically signiﬁcant in-
crease in IL-6 was after the combination of LPS and S100A8/
A9 (P < 0.05) (one-way analysis of variance) (Figure 7).
Discussion
The results from our experimental model demonstrate that
circulating S100A8/A9 serum levels correlate with diseaseajp.amjpathol.org - The American Journal of Pathology
S100A8/A9 in Glomerulonephritisseverity, mirroring our previous ﬁndings in patients with
anti-neutrophil cytoplasmic antibodyeassociated vascu-
litis,8 but additionally that S100A8/A9 deﬁciency in both
circulating hemopoietic and intrinsic renal cells protects
from development of glomerulonephritis. We investigated
the underlying basis for this and found that, although early
neutrophil inﬂux and humoral and T-cell immunity were
unaffected in Mrp14/ mice, there was a marked reduction
in glomerular macrophage inﬂux. This is consistent with the
ﬁnding that S100A8/A9 has a role in monocyte adhesion
and transmigration, mediated by CD11b expression and
activation, as well as an increase in monocyte surface
intercellular adhesion molecule-1,27 implying that deﬁ-
ciency in S100A8/A9 could lead to decreased macrophage
ability to inﬁltrate the glomerulus. However, it is perhaps
surprising that we found no signiﬁcant change in neutrophil
inﬂux as Mrp14/-deﬁcient mice demonstrate both
decreased macrophage and neutrophil inﬁltration, in a me-
chanical arterial injury model.28
A previous study3 showed no difference in the gene
expression pattern of unstimulated WT and Mrp14/ bone
marrow cells. However, crucial differences in several
genes after LPS stimulation have been demonstrated with
Mrp14/ phagocytes, demonstrating a reduced inﬂamma-
tory response.3 Consistent with these data, our results
demonstrate a decreased responsiveness to S100A8/A9 in
Mrp14/ BMDMs and renal mesangial cells compared to
WT cells. These novel, hitherto unreported, ﬁndings suggest
that S100A9 synthesis is required for complete cellular
responsiveness to the heterodimer S100A8/A9.
After glomerular inﬁltration, the monocyte/macrophage
S100A8/A9 complex appears to exert additional autocrine
and paracrine effects to further amplify the inﬂammatory
response, which results in endothelial and mesangial cell
activation. These data are consistent with other published
data, demonstrating the critical interaction between these
S100 proteins and TLR4, which results in activation of a
signal transduction cascade and the transcription of several
important proinﬂammatory cytokines, including CXCL1
and TNF-a, an effect abrogated in TLR4/ cells.10
Interestingly, endogenous TLR4 ligation by S100A8/A9
appears to be required for glomerulonephritis to develop, but
this can be overcome by sufﬁcient levels of exogenous TLR4
ligands. Our ﬁndings in glomerulonephritis recapitulate the
critical role S100A8 and S100A9 have in mediating inﬂam-
matory arthritis, which is also related to macrophage-
mediated damage.9,29 In addition, a positive feedback loop
of cytokine-mediated S100A8 and S100A9 secretion,
which, in turn, leads to S100A8-mediated secretion of
proinﬂammatory cytokines, such as IL-6, was demonstrated
in chondrocytes. These proinﬂammatory effects occurred
despite low expression of TLR4, and in the presence of an
anti-receptor for advanced glycation end products antibody,
implicating another unknown receptor(s) in mediating
proinﬂammatory effects of S100A8, at least in the cells
tested.30 Although the WT mice develop proteinuria duringThe American Journal of Pathology - ajp.amjpathol.orgNTN, the exogenous effect of S100A8/A9 on podocytes,
which are known to express TLR4, results in minimal cyto-
kine production. Our co-culture experiments demonstrate a
signiﬁcant proinﬂammatory role for S100A8/A9-positive
macrophages cultured with ECs, consistent with the notion
that S100A8/A9 ampliﬁes a proinﬂammatory response
through effects on macrophages and ECs. In addition, stim-
ulation of mesangial cells with S100A8/A9 resulted in the
production of proinﬂammatory cytokines, including MCP-1
and CXCL1, involved in macrophage and neutrophil
recruitment to the glomerulus, but this was blunted in the
MRP14-deﬁcient cells, with the exception of IL-6 secretion.
The bone marrow transplant experiments demonstrate that
hemopoietic cell Mrp14/ deﬁciency is not sufﬁcient to
prevent renal disease, but rather complete deﬁciency of
circulating and intrinsic cells is required for disease protec-
tion. These data suggest that the presence of radioresistant
bone marrowederived cells or intrinsic renal cell production
of S100A8/A9 is likely to contribute to disease. These ob-
servations are reminiscent of the data from bone marrow
chimeras used to investigate development of atheroscle-
rosis.31 Bone marrowespeciﬁc Mrp14/ deﬁciency in an
atherosclerosis mouse model was not sufﬁcient to reduce
inﬂammation, insulin resistance, or atherosclerosis, despite
ﬁnding a reduction in atherosclerosis in mice with total
MRP14 deﬁciency.28 Other nonmyeloid cell types have
experimentally been induced to produce S100A8 and/or
S100A9, including the murine kidney collecting duct32 and
microvascular ECs.33
In conclusion, we have demonstrated a crucial role for
S100A8/A9 in glomerular inﬂammation exerting a proin-
ﬂammatory effect on macrophages, and intrinsic renal
endothelial and mesangial cells, identifying it as a potential
target for immunotherapy.
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